Market Cap Overview
Market Cap
$60.44B
Share Price
$1485
Shares Outstanding
4.07B
What is GSK plc's Market Cap?
GSK plc's current Market Cap as of today is $60.44B.
Understanding Market Capitalization
Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.
- It provides a straightforward method of gauging a company's size.
- Market Cap can be used to compare companies within the same industry.
How is Market Cap calculated?
Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:
Market Cap = Current Share Price × Total Shares Outstanding
In the case of GSK plc, the market cap is calculated as $1485 x 4.07B shares = $60.44B.
As a Large Cap company, GSK plc is considered a large, well-established company.
GSK plc Historical Market Cap
GSK plc Market Cap vs Enterprise Value
Understanding Market Cap vs. Enterprise Value
While market cap represents the equity value of GSK plc, enterprise value provides a more complete picture of the company's total value by including debt and cash:
Enterprise Value = Market Cap + Total Debt - Cash and Equivalents
GSK plc's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:
- Market Cap: $60.44B
- Total Debt: $16.99B
- Cash and Equivalents: $3.69B
- Enterprise Value: $68.19B
The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.
GSK plc Annual Market Cap History
| Year | Market Cap | Change |
|---|---|---|
| 2025 | $60.44B | 10.10% |
| 2024 | $54.90B | -6.58% |
| 2023 | $58.76B | 1.53% |
| 2022 | $57.88B | 11.37% |
| 2021 | $51.97B | -3.69% |
| 2020 | $53.96B | -24.12% |
| 2019 | $71.11B | 20.10% |
| 2018 | $59.21B | 13.40% |
| 2017 | $52.21B | -14.88% |
| 2016 | $61.34B | 14.45% |
| 2015 | $53.60B | 0.26% |
| 2014 | $53.46B | -15.02% |
| 2013 | $62.91B | 18.72% |
| 2012 | $52.99B | -11.37% |
| 2011 | $59.79B | 17.34% |
| 2010 | $50.95B | -5.73% |
| 2009 | $54.05B | 0.23% |
| 2008 | $53.92B | -5.55% |
| 2007 | $57.09B | -8.28% |
| 2006 | $62.24B | -7.82% |
| 2005 | $67.52B | 19.39% |
| 2004 | $56.55B | -5.29% |
| 2003 | $59.71B | 4.85% |
| 2002 | $56.94B | -32.64% |
| 2001 | $84.54B | -8.83% |
| 2000 | $92.72B | -9.79% |
| 1999 | $102.79B | -14.47% |
| 1998 | $120.18B | 45.06% |
| 1997 | $82.85B | 53.45% |
| 1996 | $53.99B | 11.52% |
| 1995 | $48.41B | 154.42% |
| 1994 | $19.03B | -48.15% |
| 1993 | $36.70B | 0.60% |
| 1992 | $36.48B | 0.39% |
| 1991 | $36.34B | 0.37% |
| 1990 | $36.21B | 0.00% |
| 1989 | $36.21B | 101.33% |
| 1988 | $17.98B | 0.66% |
| 1987 | $17.87B | 0.00% |
| 1986 | $17.87B | 0.00% |
| 1985 | $17.87B | N/A |
Frequently Asked Questions
Related Metrics
Explore detailed financial metrics and analysis for GSK.L.